288 related articles for article (PubMed ID: 10820268)
1. The role of CD40-CD154 interaction in antiviral T cell-independent IgG responses.
Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Welsh RM; Garcea RL
J Immunol; 2000 Jun; 164(11):5877-82. PubMed ID: 10820268
[TBL] [Abstract][Full Text] [Related]
2. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.
Szomolanyi-Tsuda E; Brien JD; Dorgan JE; Garcea RL; Woodland RT; Welsh RM
Virology; 2001 Feb; 280(2):160-8. PubMed ID: 11162830
[TBL] [Abstract][Full Text] [Related]
3. T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles.
Szomolanyi-Tsuda E; Le QP; Garcea RL; Welsh RM
J Virol; 1998 Aug; 72(8):6665-70. PubMed ID: 9658113
[TBL] [Abstract][Full Text] [Related]
4. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice.
Szomolanyi-Tsuda E; Welsh RM
J Exp Med; 1996 Feb; 183(2):403-11. PubMed ID: 8627153
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting T cell-independent IgG responses require MyD88-mediated pathways and are maintained by high levels of virus persistence.
Raval FM; Mishra R; Garcea RL; Welsh RM; Szomolanyi-Tsuda E
mBio; 2013 Nov; 4(6):e00812-13. PubMed ID: 24194540
[TBL] [Abstract][Full Text] [Related]
6. T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.
Szomolanyi-Tsuda E; Seedhom MO; Carroll MC; Garcea RL
Virology; 2006 Aug; 352(1):52-60. PubMed ID: 16733062
[TBL] [Abstract][Full Text] [Related]
7. Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.
Kemball CC; Lee ED; Szomolanyi-Tsuda E; Pearson TC; Larsen CP; Lukacher AE
J Immunol; 2006 Feb; 176(3):1814-24. PubMed ID: 16424212
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
9. Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions.
Chirmule N; Tazelaar J; Wilson JM
J Immunol; 2000 Jan; 164(1):248-55. PubMed ID: 10605018
[TBL] [Abstract][Full Text] [Related]
10. Generation of protective T cell-independent antiviral antibody responses in SCID mice reconstituted with follicular or marginal zone B cells.
Guay HM; Mishra R; Garcea RL; Welsh RM; Szomolanyi-Tsuda E
J Immunol; 2009 Jul; 183(1):518-23. PubMed ID: 19542462
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
[TBL] [Abstract][Full Text] [Related]
12. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.
Borrow P; Tishon A; Lee S; Xu J; Grewal IS; Oldstone MB; Flavell RA
J Exp Med; 1996 May; 183(5):2129-42. PubMed ID: 8642323
[TBL] [Abstract][Full Text] [Related]
13. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
Lumsden JM; Williams JA; Hodes RJ
J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
[TBL] [Abstract][Full Text] [Related]
14. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
Andreasen SO; Christensen JE; Marker O; Thomsen AR
J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
[TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Jun; 164(11):6005-14. PubMed ID: 10820284
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand/CD40 deficiency.
Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens.
Pérez-Melgosa M; Hollenbaugh D; Wilson CB
J Immunol; 1999 Aug; 163(3):1123-7. PubMed ID: 10415005
[TBL] [Abstract][Full Text] [Related]
18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
19. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
20. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
